HEADER TRANSFERASE/TRANSFERASE INHIBITOR 07-DEC-12 3W33 TITLE EGFR KINASE DOMAIN COMPLEXED WITH COMPOUND 19B COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPIDERMAL GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 696-1022; COMPND 5 SYNONYM: PROTO-ONCOGENE C-ERBB-1, RECEPTOR TYROSINE-PROTEIN KINASE COMPND 6 ERBB-1; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EGFR, ERBB, ERBB1, HER1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS ANTI-ONCOGENE, CELL CYCLE, DISEASE MUTATION, KINASE DOMAIN, RECEPTOR, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.SOGABE,Y.KAWAKITA REVDAT 2 14-AUG-13 3W33 1 JRNL REVDAT 1 06-MAR-13 3W33 0 JRNL AUTH Y.KAWAKITA,M.SETO,T.OHASHI,T.TAMURA,T.YUSA,H.MIKI,H.IWATA, JRNL AUTH 2 H.KAMIGUCHI,T.TANAKA,S.SOGABE,Y.OHTA,T.ISHIKAWA JRNL TITL DESIGN AND SYNTHESIS OF NOVEL PYRIMIDO[4,5-B]AZEPINE JRNL TITL 2 DERIVATIVES AS HER2/EGFR DUAL INHIBITORS JRNL REF BIOORG.MED.CHEM. V. 21 2250 2013 JRNL REFN ISSN 0968-0896 JRNL PMID 23490150 JRNL DOI 10.1016/J.BMC.2013.02.014 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 35913 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1888 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.75 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2595 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.10 REMARK 3 BIN R VALUE (WORKING SET) : 0.3360 REMARK 3 BIN FREE R VALUE SET COUNT : 165 REMARK 3 BIN FREE R VALUE : 0.3770 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2396 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 127 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.62 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.90000 REMARK 3 B22 (A**2) : 0.02000 REMARK 3 B33 (A**2) : -2.92000 REMARK 3 B12 (A**2) : -0.00000 REMARK 3 B13 (A**2) : -0.00000 REMARK 3 B23 (A**2) : -0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.109 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.109 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.077 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.878 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.949 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2520 ; 0.009 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3412 ; 1.411 ; 1.993 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 299 ; 5.416 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;33.694 ;23.551 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 465 ;13.939 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;13.043 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 379 ; 0.090 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1916 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 701 A 1018 REMARK 3 RESIDUE RANGE : A 1101 A 1101 REMARK 3 ORIGIN FOR THE GROUP (A): 18.7123 25.5688 15.3000 REMARK 3 T TENSOR REMARK 3 T11: 0.0285 T22: 0.0419 REMARK 3 T33: 0.0559 T12: -0.0020 REMARK 3 T13: -0.0045 T23: -0.0065 REMARK 3 L TENSOR REMARK 3 L11: 0.1591 L22: 0.5810 REMARK 3 L33: 0.2852 L12: -0.0458 REMARK 3 L13: 0.1346 L23: -0.2681 REMARK 3 S TENSOR REMARK 3 S11: -0.0502 S12: -0.0029 S13: -0.0256 REMARK 3 S21: 0.0704 S22: 0.0289 S23: 0.0439 REMARK 3 S31: -0.0885 S32: -0.0033 S33: 0.0213 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3W33 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-DEC-12. REMARK 100 THE RCSB ID CODE IS RCSB095824. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-DEC-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97649 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38002 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04900 REMARK 200 FOR THE DATA SET : 26.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.81000 REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1XKK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M MES, 0.2M LITHIUM SULFATE, 25% REMARK 280 PEG 3350, PH 5.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.43900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.21200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.58750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.21200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.43900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.58750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 693 REMARK 465 ALA A 694 REMARK 465 MET A 695 REMARK 465 GLY A 696 REMARK 465 GLU A 697 REMARK 465 ALA A 698 REMARK 465 PRO A 699 REMARK 465 ASN A 700 REMARK 465 GLU A 749 REMARK 465 ALA A 750 REMARK 465 THR A 751 REMARK 465 SER A 752 REMARK 465 PRO A 753 REMARK 465 GLY A 863 REMARK 465 ALA A 864 REMARK 465 GLU A 865 REMARK 465 GLU A 866 REMARK 465 LYS A 867 REMARK 465 GLU A 868 REMARK 465 TYR A 869 REMARK 465 HIS A 870 REMARK 465 ALA A 871 REMARK 465 GLU A 872 REMARK 465 GLY A 873 REMARK 465 GLY A 874 REMARK 465 GLU A 1004 REMARK 465 GLU A 1005 REMARK 465 ASP A 1006 REMARK 465 MET A 1007 REMARK 465 PRO A 1019 REMARK 465 GLN A 1020 REMARK 465 GLN A 1021 REMARK 465 GLY A 1022 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 783 -133.08 -130.54 REMARK 500 ARG A 836 -14.05 80.46 REMARK 500 ASP A 837 45.60 -145.72 REMARK 500 LEU A 861 -35.27 -38.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2116 DISTANCE = 5.06 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE W19 A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1102 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3POZ RELATED DB: PDB REMARK 900 RELATED ID: 3W32 RELATED DB: PDB DBREF 3W33 A 696 1022 UNP P00533 EGFR_HUMAN 696 1022 SEQADV 3W33 GLY A 693 UNP P00533 EXPRESSION TAG SEQADV 3W33 ALA A 694 UNP P00533 EXPRESSION TAG SEQADV 3W33 MET A 695 UNP P00533 EXPRESSION TAG SEQRES 1 A 330 GLY ALA MET GLY GLU ALA PRO ASN GLN ALA LEU LEU ARG SEQRES 2 A 330 ILE LEU LYS GLU THR GLU PHE LYS LYS ILE LYS VAL LEU SEQRES 3 A 330 GLY SER GLY ALA PHE GLY THR VAL TYR LYS GLY LEU TRP SEQRES 4 A 330 ILE PRO GLU GLY GLU LYS VAL LYS ILE PRO VAL ALA ILE SEQRES 5 A 330 LYS GLU LEU ARG GLU ALA THR SER PRO LYS ALA ASN LYS SEQRES 6 A 330 GLU ILE LEU ASP GLU ALA TYR VAL MET ALA SER VAL ASP SEQRES 7 A 330 ASN PRO HIS VAL CYS ARG LEU LEU GLY ILE CYS LEU THR SEQRES 8 A 330 SER THR VAL GLN LEU ILE THR GLN LEU MET PRO PHE GLY SEQRES 9 A 330 CYS LEU LEU ASP TYR VAL ARG GLU HIS LYS ASP ASN ILE SEQRES 10 A 330 GLY SER GLN TYR LEU LEU ASN TRP CYS VAL GLN ILE ALA SEQRES 11 A 330 LYS GLY MET ASN TYR LEU GLU ASP ARG ARG LEU VAL HIS SEQRES 12 A 330 ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL LYS THR PRO SEQRES 13 A 330 GLN HIS VAL LYS ILE THR ASP PHE GLY LEU ALA LYS LEU SEQRES 14 A 330 LEU GLY ALA GLU GLU LYS GLU TYR HIS ALA GLU GLY GLY SEQRES 15 A 330 LYS VAL PRO ILE LYS TRP MET ALA LEU GLU SER ILE LEU SEQRES 16 A 330 HIS ARG ILE TYR THR HIS GLN SER ASP VAL TRP SER TYR SEQRES 17 A 330 GLY VAL THR VAL TRP GLU LEU MET THR PHE GLY SER LYS SEQRES 18 A 330 PRO TYR ASP GLY ILE PRO ALA SER GLU ILE SER SER ILE SEQRES 19 A 330 LEU GLU LYS GLY GLU ARG LEU PRO GLN PRO PRO ILE CYS SEQRES 20 A 330 THR ILE ASP VAL TYR MET ILE MET VAL LYS CYS TRP MET SEQRES 21 A 330 ILE ASP ALA ASP SER ARG PRO LYS PHE ARG GLU LEU ILE SEQRES 22 A 330 ILE GLU PHE SER LYS MET ALA ARG ASP PRO GLN ARG TYR SEQRES 23 A 330 LEU VAL ILE GLN GLY ASP GLU ARG MET HIS LEU PRO SER SEQRES 24 A 330 PRO THR ASP SER ASN PHE TYR ARG ALA LEU MET ASP GLU SEQRES 25 A 330 GLU ASP MET ASP ASP VAL VAL ASP ALA ASP GLU TYR LEU SEQRES 26 A 330 ILE PRO GLN GLN GLY HET W19 A1101 35 HET SO4 A1102 5 HETNAM W19 4-{[4-(1-BENZOTHIOPHEN-4-YLOXY)-3-CHLOROPHENYL]AMINO}- HETNAM 2 W19 N-(2-HYDROXYETHYL)-8,9-DIHYDRO-7H-PYRIMIDO[4,5- HETNAM 3 W19 B]AZEPINE-6-CARBOXAMIDE HETNAM SO4 SULFATE ION FORMUL 2 W19 C25 H22 CL N5 O3 S FORMUL 3 SO4 O4 S 2- FORMUL 4 HOH *127(H2 O) HELIX 1 1 LYS A 708 THR A 710 5 3 HELIX 2 2 ALA A 755 VAL A 769 1 15 HELIX 3 3 CYS A 797 LYS A 806 1 10 HELIX 4 4 ASP A 807 ILE A 809 5 3 HELIX 5 5 GLY A 810 ARG A 831 1 22 HELIX 6 6 ALA A 839 ARG A 841 5 3 HELIX 7 7 GLY A 857 LEU A 862 1 6 HELIX 8 8 PRO A 877 MET A 881 5 5 HELIX 9 9 ALA A 882 ARG A 889 1 8 HELIX 10 10 THR A 892 THR A 909 1 18 HELIX 11 11 PRO A 919 SER A 921 5 3 HELIX 12 12 GLU A 922 LYS A 929 1 8 HELIX 13 13 THR A 940 TRP A 951 1 12 HELIX 14 14 ASP A 954 ARG A 958 5 5 HELIX 15 15 LYS A 960 ARG A 973 1 14 HELIX 16 16 ASP A 974 LEU A 979 1 6 HELIX 17 17 GLY A 983 MET A 987 5 5 HELIX 18 18 SER A 995 ASP A 1003 1 9 HELIX 19 19 ASP A 1012 LEU A 1017 1 6 SHEET 1 A 6 ARG A 705 ILE A 706 0 SHEET 2 A 6 LEU A 777 LEU A 782 1 O ILE A 780 N ARG A 705 SHEET 3 A 6 VAL A 786 GLN A 791 -1 O ILE A 789 N GLY A 779 SHEET 4 A 6 ILE A 740 LEU A 747 -1 N LYS A 745 O LEU A 788 SHEET 5 A 6 GLY A 724 TRP A 731 -1 N TRP A 731 O ILE A 740 SHEET 6 A 6 PHE A 712 SER A 720 -1 N GLY A 719 O VAL A 726 SHEET 1 B 2 VAL A 843 THR A 847 0 SHEET 2 B 2 HIS A 850 ILE A 853 -1 O LYS A 852 N LEU A 844 SITE 1 AC1 15 ALA A 743 LYS A 745 CYS A 775 ARG A 776 SITE 2 AC1 15 LEU A 788 THR A 790 GLN A 791 MET A 793 SITE 3 AC1 15 GLY A 796 LEU A 844 THR A 854 ASP A 855 SITE 4 AC1 15 PHE A 856 HOH A2007 HOH A2011 SITE 1 AC2 6 ARG A 803 LYS A 913 LYS A 970 ARG A 977 SITE 2 AC2 6 HOH A2058 HOH A2119 CRYST1 46.878 69.175 104.424 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021332 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014456 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009576 0.00000 MASTER 340 0 2 19 8 0 6 6 0 0 0 26 END